J. R. Dorkin
Molecular Biology · 2008–2016
A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 132 citations into it; #16,361 of 17,773 by trust here, #2,245 by citations
Whom J. R. Dorkin trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- W. Aird (in Molecular Biology)
Who trusts J. R. Dorkin
- Robert Langer (in Molecular Biology)
Papers from J. R. Dorkin's perspective
Ordered by how strongly the researchers J. R. Dorkin trusts endorse each paper. Same corpus, a different order for every researcher.
- Inhibition of respiratory viruses by nasally administered siRNA (Nature Medicine)
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics (Nature Biotechnology)
- Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors (Nature Biotechnology)
- Interfering with disease: a progress report on siRNA-based therapeutics (Nature reviews. Drug discovery)
- The new frontier of genome engineering with CRISPR-Cas9
- The RNAi revolution (Nature)
- Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs (Nature Biotechnology)
- Therapeutic Genome Editing: Prospects and Challenges (Nature Medicine)
- Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA (Nature Biotechnology)
- Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* (Journal of Biological Chemistry)
Their papers
- A combinatorial library of lipid-like materials for delivery of RNAi therapeutics (2008) — 1,181 citations
- Delivery materials for siRNA therapeutics. (2013) — 1,696 citations
- Non-viral vectors for gene-based therapy (2014) — 2,860 citations
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms. (2010) — 955 citations
- Rational design of cationic lipids for siRNA delivery (2010) — 1,657 citations
- Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs. (2015) — 688 citations
- Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) — 823 citations
- Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy (2016) — 632 citations